Ryan Fukushima
Net worth: 45 M $ as of 2026-06-29
Net worth: 45 M $ as of 2026-06-29
Ryan Fukushima is the founder of Pathos AI, Inc. Currently, Mr. Fukushima is Chief Executive Officer-Data & Apps at Tempus AI, Inc., starting in 2026.
Formerly, Mr. Fukushima was Chief Executive Officer at Rain Oncology, Inc., Principal at Michigan Ross Zell Lurie Institute, Associate at TechStars Central, LLC, Principal at Tapjoy, Inc., Vice President at Lightbank LLC from 2014 to 2016, Associate at Huron River Venture Partners LLC, and Senior Associate at Hyde Park Venture Partners Management LLC from 2013 to 2014.
Education includes an MBA and graduate studies at the University of Michigan, and undergraduate studies at California Polytechnic State University (San Luis Obispo).
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-07-07 | 771,321 ( 0.44% ) | 45 M $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| TEMPUS AI, INC. | Corporate Officer/Principal | 2026-01-31 |
Pathos AI, Inc.
Pathos AI, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that engages in re-engineering drug development activities | Founder | - |
| Companies | Position | End |
|---|---|---|
Lightbank LLC
Lightbank LLC Investment ManagersFinance Lightbank invests in companies located in the United States. The firm targets companies operating in the fields of internet, software, climate tech and consumer brands. It provides financing for seed, early and later stage capital requirements. | Private Equity Investor | 2016-12-30 |
Hyde Park Venture Partners Management LLC
Hyde Park Venture Partners Management LLC Investment ManagersFinance Hyde Park Venture Partners invests in companies located in the United States, primarily in Midwest region, Toronto, and Atlanta. The firm focuses on the technology sector. It participates in equity financing for early stage transactions. | Corporate Officer/Principal | 2014-01-31 |
| RAIN ONCOLOGY INC. | Chief Executive Officer | - |
Michigan Ross Zell Lurie Institute / Venture Capital/
Michigan Ross Zell Lurie Institute / Venture Capital/ Investment ManagersFinance Zell Lurie Institute invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It participates in early-stage transactions. | Corporate Officer/Principal | - |
Huron River Venture Partners LLC
Huron River Venture Partners LLC Investment ManagersFinance Huron River Venture invests in companies located in the United States. The firm focuses on sectors such as agriculture, transportation, energy and technology companies. It participates in seed and early stage capital requirements with an investment size ranging from USD 1-5 million and makes co-investments. It acts as lead investor and takes majority position in the companies and also takes a seat on the board of directors. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 12 |
|---|---|
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Polytechnic State University (San Luis Obispo)
California Polytechnic State University (San Luis Obispo) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Michigan Ross Zell Lurie Institute / Venture Capital/
Michigan Ross Zell Lurie Institute / Venture Capital/ Investment ManagersFinance Zell Lurie Institute invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It participates in early-stage transactions. | Finance |
TechStars Central, LLC
TechStars Central, LLC Investment ManagersFinance TechStars Central is an active manager which invests in companies located in the United States. The firm targets companies operating in the field of commercial services and technology services. They provides financing for accelerator/incubator and seed stage capital requirements. | Finance |
Tapjoy, Inc.
Tapjoy, Inc. Packaged SoftwareTechnology Services Provides social and mobile applications | Technology Services |
Lightbank LLC
Lightbank LLC Investment ManagersFinance Lightbank invests in companies located in the United States. The firm targets companies operating in the fields of internet, software, climate tech and consumer brands. It provides financing for seed, early and later stage capital requirements. | Finance |
Stephen M. Ross School of Business
Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Huron River Venture Partners LLC
Huron River Venture Partners LLC Investment ManagersFinance Huron River Venture invests in companies located in the United States. The firm focuses on sectors such as agriculture, transportation, energy and technology companies. It participates in seed and early stage capital requirements with an investment size ranging from USD 1-5 million and makes co-investments. It acts as lead investor and takes majority position in the companies and also takes a seat on the board of directors. | Finance |
Hyde Park Venture Partners Management LLC
Hyde Park Venture Partners Management LLC Investment ManagersFinance Hyde Park Venture Partners invests in companies located in the United States, primarily in Midwest region, Toronto, and Atlanta. The firm focuses on the technology sector. It participates in equity financing for early stage transactions. | Finance |
Tempus AI, Inc.
Tempus AI, Inc. Packaged SoftwareTechnology Services Develops clinical & molecular data platform for healthcare | Technology Services |
Rain Oncology, Inc.
Rain Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage precision oncology company that develops therapeutics for cancer patients | Health Technology |
Pathos AI, Inc.
Pathos AI, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that engages in re-engineering drug development activities | Health Technology |
Select your edition
All financial news and data tailored to specific country editions